Business / Finance

RSS
Mead Johnson's 2010 GAAP net earnings increase to $2.20 per diluted share

Mead Johnson's 2010 GAAP net earnings increase to $2.20 per diluted share

Baxter fourth quarter net income declines 26% to $423 million

Baxter fourth quarter net income declines 26% to $423 million

Despite reimbursement cuts the diagnostic imaging market to grow at 5% over next five years: MRG

Despite reimbursement cuts the diagnostic imaging market to grow at 5% over next five years: MRG

PSS World Medical third quarter consolidated earnings per diluted share increase 16.6% to $0.35

PSS World Medical third quarter consolidated earnings per diluted share increase 16.6% to $0.35

NuGEN, Caliper enter co-marketing agreement in next generation sequencing sample preparation methods

NuGEN, Caliper enter co-marketing agreement in next generation sequencing sample preparation methods

Merck Canada invests in CQDM to support biopharmaceutical research

Merck Canada invests in CQDM to support biopharmaceutical research

Healthcare at Home acquires Sciensus

Healthcare at Home acquires Sciensus

QIAGEN announces formation of subsidiary in India

QIAGEN announces formation of subsidiary in India

FDA, Simulations Plus sign RCA to develop QSAR toxicity models

FDA, Simulations Plus sign RCA to develop QSAR toxicity models

Alcon fourth quarter sales raise 5.7% to $1.81 billion in 2010

Alcon fourth quarter sales raise 5.7% to $1.81 billion in 2010

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Teva announces acquisition of Corporación Infarmasa

Teva announces acquisition of Corporación Infarmasa

It may not be the end for employer-sponsored insurance

It may not be the end for employer-sponsored insurance

Inviragen completes memorandum of understanding with Duke-NUS

Inviragen completes memorandum of understanding with Duke-NUS

Nexstim closes additional equity financing for approximately EUR 11.4 million

Nexstim closes additional equity financing for approximately EUR 11.4 million

CyDex stockholders approve merger with Ligand

CyDex stockholders approve merger with Ligand

Anapharm Europe, PharmaNet officially terminate joint venture

Anapharm Europe, PharmaNet officially terminate joint venture

Teva, APP enter agreement for launch of generic Gemzar

Teva, APP enter agreement for launch of generic Gemzar

Lehigh Valley Physician Hospital, Aetna reach agreement on new four-year contract for LVHN

Lehigh Valley Physician Hospital, Aetna reach agreement on new four-year contract for LVHN

ICV Partners acquires Stauber Performance Ingredients

ICV Partners acquires Stauber Performance Ingredients